Piramal Pharma Q1 Results

  • BSE: 543635
  • NSE: PPLPHARMA
  • ISIN: INE0DK501011
  • Sector: -
BSE
217.1-8.85 (-3.92%)
Volume5.72 L
Updated: Mon 9 Sep, 2024 | 15:40:22
NSE
217.34-8.97 (-3.96%)
Volume13.71 M
Updated: Mon 9 Sep, 2024 | 15:43:53
Today: 214.85
226.60
52-Wk: 87.55
227.90

Q1 Results Highlights

  • Total Income
    ₹1,951.14 Cr.
    (11.57%)
  • Operating Profit
    ₹532.07 Cr.
    (8.30%)
  • Profit After Tax
    ₹-88.64 Cr.
    (-10.08%)
  • Operating Margin
    27.27%
    (-2.93%)
Note: Comparison is on YoY basis

Quarterly - Piramal Pharma Q1 Results

*All figures in crores except per share values
Fiscal PeriodJun 24Mar 24QoQ CompJun 23YoY Comp
Total Revenue 1,951.142,552.36-23.56%1,748.8511.57%
Selling/ General/ Admin Expenses Total 579.69526.0510.20%495.5416.98%
Depreciation/ Amortization 184.55196.13-5.90%173.616.30%
Other Operating Expenses Total -19.54-26.38-25.93%-38.31-49.00%
Total Operating Expense 1,419.071,740.71-18.48%1,257.5712.84%
Operating Income 532.07811.65-34.45%491.288.30%
Net Income Before Taxes -45.08227.480.00%-107.11-57.91%
Net Income -88.64101.270.00%-98.58-10.08%
Diluted Normalized EPS -0.670.860.00%-0.83-19.28%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts